HealthMate Inc said itsauditors, Laventhol and Horwath, indicated they will issue aqualified opinion on the company's financial statements.    The company, which went public in March 1985, earlierreported losses for the fourth quarter.    It said the auditor's statement, known as a "subject to"opinion, cautions that, because of continuing operating lossesand negative cash flow, it must achieve profitable operationsor acquire additional equity capital or other financing tocontinue in existence.    HealthMate reported a loss for the year of 1,512,534 dlrs,or 17 cts a share on revenues of 1.4 mln dlrs. A year ago, ithad a loss of 1,553,592 dlrs, or 20 cts a share on revenues of515,225 dlrs.    It said the increased sales reflect initial shipments ofits FluoroScan Imaging Systems, low radiation X-ray imagingdevices that recently were classified by UnderwritersLaboratories Inc. Reuter&#3;